GE Healthcare, which has participated in the Chain Expo for three consecutive years, took "Domestic Innovation, Win-win with Tough Chain" as its theme this year, exhibiting more than ten domestic high-end medical equipment products covering CT, MRI and other fields, as well as core components such as CT bearings and MRI superconducting wires, presenting the results of comprehensive localization.

Chen Heqiang, Vice President of GE Healthcare China and General Manager of Supply Chain, introduced that in recent years, GE Healthcare's local R&D has also made great progress. Among the full range of products sold in the Chinese market, the proportion of local R&D has exceeded 50%, and the average annual domestic procurement amount has reached nearly 10 billion yuan, which continues to drive the growth of more than 1,000 supply chain partners in the four major industrial clusters of Beijing-Tianjin-Hebei, Chengdu-Chongqing, Yangtze River Delta, and Greater Bay Area, and has cultivated more than 160 specialized, new, small giants and high-tech enterprises from small to large and then strong, and have world-class quality and scale.

Chen Heqiang said that with the help of the Chain Expo, GE Healthcare also focused on showing its latest progress in the green supply chain this year. The biggest highlight is the joint establishment of the "China Medical Equipment Green Supply Chain Innovation Ecosystem Alliance" by multiple parties, and joined hands with core suppliers such as Luoyang Bearing and Western Superconducting to focus on green design, low-carbon manufacturing and other links to promote the industry's transformation to "low energy consumption and high efficiency"; at the same time, around the regional industrial chain, it will vigorously promote the supply chain and innovation chain to move towards lean, intelligent and green.

Novo Nordisk: Three major chains empower industry innovation and development

Novo Nordisk, which appeared at the Chain Expo for the third time, displayed its achievements in China for more than 30 years on a 425-square-meter booth.

It can be seen from the display that Novo Nordisk is deeply empowering the industry's innovation and development by building the three core driving forces of "new quality R&D chain", "high-end manufacturing chain" and "healthy ecological chain". In terms of the R&D chain, Novo Nordisk actively promotes the integration of local R&D and global wisdom. It has the first R&D center established by a multinational pharmaceutical company in China. Its INNOVO® open innovation platform has successfully facilitated 46 collaborations and helped 2 projects enter the global pipeline. Its "China Co-Creation" project has achieved the simultaneous development, approval and listing of innovative drugs such as Novovac® at home and abroad. In terms of the manufacturing chain, the company continues to increase its investment in the Tianjin production plant, serving the global market with high-tech, high-efficiency and high-quality production, and building a green and sustainable supply chain. In terms of the ecological chain, in the first half of this year, it joined hands with Tencent Health, JD Health, Ping An Health, and Ali Health, four major platforms, to cross-border build a digital chronic disease management ecological chain, so that the concept of early screening, early diagnosis, and early treatment can be fully realized in the smart medical scene.

Zhou Xiaping, global senior vice president and president of Greater China of Novo Nordisk, said that as a three-year full-time student of the Chain Expo, we were able to work together with more partners in the industrial chain this year to create a full-scenario health management ecosystem and inject strong momentum into the sustainable development of chronic disease management.

Medtronic: Deeply cultivate the local innovation chain and serve the global sharing Stainless steel industrial connectors: precise fit and secure connecti

Medtronic, a global medical technology company participating in the exhibition for the first time, demonstrated the five pillars of medical innovation integration chain, local intelligent manufacturing chain, value co-creation chain, intelligent service chain and collaborative supply and win-win chain, which jointly drive its transformation from "innovative technology exporter" to "local ecological co-builder".

Gu Yushao, Medtronic's global senior vice president and president of Greater China, said that Medtronic has built an ecosystem with nearly 7,000 suppliers in China. In fiscal year 2025, Medtronic's procurement from China will be close to 5 billion yuan, of which 90% of indirect procurement will be undertaken by local suppliers, and about 90% of key components and raw materials in direct procurement will be supplied to overseas factories. He firmly believes that China will become the world's largest medical market and source of innovation. In the future, Medtronic will continue to strengthen the layout of the local value chain, with the goal of "symbiosis, co-creation and win-win", and jointly promote the stable and long-term development of the medical technology supply chain.

In addition, there is Sanofi, which presents "one vaccine, global collaboration" through the cross-border full chain of "French strain-Shenzhen production-China vaccination", and AstraZeneca, which supports China's zero-carbon goal by building a world-class "lighthouse factory" and leads the industry's green transformation... This Chain Expo has not only become a window for global medical companies to showcase their supply chain innovation achievements, but also built an open platform for the symbiotic development of the industry. Medical giants are working with Chinese partners to drive the industrial chain with the innovation chain, and jointly open a new chapter of open cooperation and shared future in the health industry.Stainless steel industrial connectors: precise fit and secure connecti